Leerink Partners Downgrades ARS Pharmaceuticals Inc (SPRY) to Market Perform
Tweet Send to a Friend
Leerink Partners analyst Roanna Ruiz downgraded ARS Pharmaceuticals Inc (NASDAQ: SPRY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
